Dashboard
Manage Tickers

CYTH


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
03/25/2025 12:10:17

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
03/20/2025 21:06:20

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
02/10/2025 21:05:43

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
02/10/2025 12:05:39

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
02/07/2025 21:05:49

cyclo-therapeutics-presents-preliminary-data-from-phase-3-transportnpc-study-of-trappsol-with-6-of-7-patients-showing-stabilization-or-improvement-in-clinical-global-impression-over-48-weeks-topline-48-week-interim-data-expected-in-h1-2025
Cyclo Therapeutics Presents Preliminary Da...
02/07/2025 13:09:55

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
12/04/2024 21:06:10

cyclo-therapeutics-q3-eps-031-misses-016-estimate-sales-23377k-miss-29400k-estimate
Cyclo Therapeutics Q3 EPS $(0.31) Misses $...
11/14/2024 13:38:06

Cyclo Therapeutics (NASDAQ:CYTH) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of ...

cyclo-therapeutics-shares-are-trading-higher-after-the-company-announced-the-presentation-of-preliminary-data-from-its-ongoing-pivotal-phase-3-study-and-substudy-evaluating-trappsol-cyclo-for-the-treatment-of-niemann-pick-disease-type-c1
Cyclo Therapeutics shares are trading high...
09/05/2024 13:09:01

cyclo-therapeutics-presents-preliminary-data-from-phase-3-study-of-trappsol-cyclo-for-niemann-pick-disease-type-c1-at-ssiem-symposium-topline-data-expected-h1-2025
Cyclo Therapeutics Presents Preliminary Da...
09/05/2024 13:06:33

this-hershey-analyst-turns-bearish-here-are-top-5-downgrades-for-tuesday
This Hershey Analyst Turns Bearish; Here A...
08/27/2024 13:00:52

maxim-group-downgrades-cyclo-therapeutics-to-hold
Maxim Group Downgrades Cyclo Therapeutics ...
08/27/2024 12:32:28

Maxim Group analyst Jason McCarthy downgrades Cyclo Therapeutics (NASDAQ:CYTH) from Buy to Hold.

ascendiant-capital-maintains-buy-on-cyclo-therapeutics-lowers-price-target-to-095
Ascendiant Capital Maintains Buy on Cyclo ...
08/26/2024 10:10:17

Ascendiant Capital analyst Lucas Ward maintains Cyclo Therapeutics (NASDAQ:CYTH) with a Buy and lowers the price target from...

hc-wainwright--co-downgrades-cyclo-therapeutics-to-neutral-lowers-price-target-to-095
HC Wainwright & Co. Downgrades Cyclo Thera...
08/23/2024 11:23:33

HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Cyclo Therapeutics (NASDAQ:CYTH) from Buy to Neutral and l...

nasdaq-down-over-200-points-williams-sonoma-shares-tumble-after-q2-results
Nasdaq Down Over 200 Points; Williams-Sono...
08/22/2024 18:47:30

gold-down-over-1-us-initial-jobless-claims-increase
Gold Down Over 1%; US Initial Jobless Clai...
08/22/2024 16:16:23

dow-jumps-100-points-bjs-wholesale-earnings-top-estimates
Dow Jumps 100 Points; BJ's Wholesale Earni...
08/22/2024 13:54:09

Core News & Articles
Rafael And Cyclo Therapeutics Have Agreed ...
08/22/2024 10:52:33

On consummation of the merger, Rafael will issue Class B shares to Cyclo Therapeutics' shareholders, based on an exchange r...

hc-wainwright--co-reiterates-buy-on-cyclo-therapeutics-maintains-3-price-target
HC Wainwright & Co. Reiterates Buy on Cycl...
08/16/2024 16:12:53

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Cyclo Therapeutics (NASDAQ:CYTH) with a Buy and maintains ...

cyclo-therapeutics-q2-eps-021-misses-016-estimate-sales-12310k-miss-26750k-estimate
Cyclo Therapeutics Q2 EPS $(0.21) Misses $...
08/15/2024 13:03:11

Cyclo Therapeutics (NASDAQ:CYTH) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION